The Gemelli University Hospital is a large general hospital in Rome, Italy. With 1575 beds, it is the second-largest hospital in Italy, the largest hospital in Rome and one of the largest private hospitals in Europe.

There are 1,575 beds in Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica.

During the past decade, Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica" #1 collaborator was "ERIC Group" with 1 trials as a collaborator and "Hematology Project Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica" are "Acute Myeloid Leukemia" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Acute Promyelocytic Leukemia" (1 trials), "Chronic Lymphoid Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica" in a lesser frequency.

Most popular intervention types in "Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica" are "Drug" (7 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "Venetoclax" (2 trials), "Allogeneic stem cell transplantation" (1 trials), "Arsenic Trioxide" (1 trials) and "Azacitidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".